David Burg's most recent trade in WSFS Financial Corp. was a trade of 3,048 Common Stock done at an average price of $53.5 . Disclosure was reported to the exchange on Feb. 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| WSFS Financial Corp. | David Burg | Executive Vice President | Grant, award, or other acquisition of securities at price $ 53.49 per share. | 27 Feb 2025 | 3,048 | 30,733 (0%) | 0% | 53.5 | 163,038 | Common Stock |
| WSFS Financial Corp. | David Burg | Executive Vice President | Grant, award, or other acquisition of securities at price $ 50.57 per share. | 15 Aug 2024 | 15,820 | 27,685 (0%) | 0% | 50.6 | 800,017 | Common Stock |
| WSFS Financial Corp. | David Burg | Executive Vice President | Grant, award, or other acquisition of securities at price $ 50.57 per share. | 15 Aug 2024 | 11,865 | 11,865 (0%) | 0% | 50.6 | 600,013 | Common Stock |
| RVL Pharmaceuticals plc | David F. Burgstahler | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 27 Jan 2023 | 1,032,995 | 0 (0%) | 1% | 0 | Ordinary Shares | |
| RVL Pharmaceuticals plc | David F. Burgstahler | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 08 Aug 2022 | 8,000,000 | 23,730,864 (40%) | 13% | 1.6 | 12,400,000 | Ordinary Shares |
| RVL Pharmaceuticals plc | David F. Burgstahler | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 20 Nov 2020 | 4,936,926 | 0 (0%) | 8% | - | Ordinary Shares |